Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to -$291000.0.

  • Bioventus' Change in Inventory fell 11157.06% to -$291000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 26323.85%. This contributed to the annual value of $16.4 million for FY2024, which is 17432.82% up from last year.
  • Per Bioventus' latest filing, its Change in Inventory stood at -$291000.0 for Q3 2025, which was down 11157.06% from $2.8 million recorded in Q2 2025.
  • Bioventus' Change in Inventory's 5-year high stood at $10.0 million during Q4 2022, with a 5-year trough of -$8.1 million in Q4 2023.
  • For the 5-year period, Bioventus' Change in Inventory averaged around $2.2 million, with its median value being $2.8 million (2025).
  • As far as peak fluctuations go, Bioventus' Change in Inventory tumbled by 24122.9% in 2021, and later soared by 172392.64% in 2023.
  • Over the past 5 years, Bioventus' Change in Inventory (Quarter) stood at -$1.7 million in 2021, then surged by 692.59% to $10.0 million in 2022, then crashed by 181.34% to -$8.1 million in 2023, then soared by 168.38% to $5.6 million in 2024, then crashed by 105.23% to -$291000.0 in 2025.
  • Its last three reported values are -$291000.0 in Q3 2025, $2.8 million for Q2 2025, and $1.9 million during Q1 2025.